2020 ttf alk session - lin - tkis for ros1
Published 3 years ago • 90 plays • Length 25:07Download video MP4
Download video MP3
Similar videos
-
2:16
2020 ttf alk session qa panel ros1 patients on immunotherapy chemotherapy combinations
-
3:24
2020 ttf alk qa panel ros1 clinical trial updates
-
1:50
2020 ttf alk/ros session qa panel the difference in efficacy of tkis in different patients
-
23:44
2020 ttf alk session raez sequence of alk inhibitors
-
1:57
video 2020 ttf alk/ros session qa panel ros1 patients - chemo after resistance to inhibitor therapy?
-
3:06
2020 ttf alk session qa panel progression on 2nd-gen alk inhibitor if biopsy shows no alk mutation
-
2:36
2020 ttf alk session qa panel information on the crown trial and firstline lorlatinib
-
4:08
2020 ttf alk/ros session qa panel treatment decisions for simultaneous egfr and ros1 mutation
-
2:28
2020 ttf alk session qa panel the future of mek inhibitors
-
1:20
2020 ttf alk/ros session qa panel ros1 patient on crizotinib, brain metastases treated with srt
-
4:20
video 2020 ttf alk/ros session qa panel the efficacy of dose reduction or interruption of crizotinib
-
3:46
2020 ttf alk session qa panel the use of an alk tki post chemoradiation for stage 3b lung cancer
-
1:43
2020 ttf alk session qa panel reducing dosage on lorlatinib vs switching to a different agent
-
1:54
grace targeted therapies lung cancer 2021 - ros1 pairing partner and influence on ros1 tkis?
-
3:33
grace targeted therapies in lung cancer 2021 - liquid biopsies - tki resistance for alk, ros1 & ret
-
2:02
grace targeted therapies lung cancer 2021 - second line ros1 medication off-label
-
2:07
grace targeted therapies lung cancer 2021 - ros1 & alk treatments transform neuroendocrine tumor
-
7:49
alk nsclc treatment options - 2022 program: targeted therapies forum